Global Paclitaxel Injection Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 21-Feb-2019
No. of pages: 124

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

Scope of the Report:

In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.

In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.

In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What's more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.

At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.

In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.

The worldwide market for Paclitaxel Injection is expected to grow at a CAGR of roughly 11.0% over the next five years, will reach 3680 million US$ in 2024, from 2180 million US$ in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Paclitaxel Injection in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Bristol-Myers Squibb

- Celgene Corporation

- Hospira

- Biological E.

- Taj Accura

- Khandelwal Laboratories

- Luye Pharma

- Beijing Youcare

- Beijing Union

- Haiyao

- Chuntch

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Drug Strength

- Raw meterial Paclitaxel API source

Market Segment by Applications, can be divided into

- Ovarian cancer

- Breast cancer

- Cervical cancer

- Pancreatic cancer

- Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Paclitaxel Injection product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Paclitaxel Injection, with price, sales, revenue and global market share of Paclitaxel Injection in 2017 and 2018.

Chapter 3, the Paclitaxel Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Paclitaxel Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Paclitaxel Injection market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Paclitaxel Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Paclitaxel Injection Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview
1.1 Paclitaxel Injection Introduction
1.2 Market Analysis by Type
1.2.1 Drug Strength
1.2.2 Raw meterial Paclitaxel API source
1.3 Market Analysis by Applications
1.3.1 Ovarian cancer
1.3.2 Breast cancer
1.3.3 Cervical cancer
1.3.4 Pancreatic cancer
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 Paclitaxel Injection Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Celgene Corporation
2.2.1 Business Overview
2.2.2 Paclitaxel Injection Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Hospira
2.3.1 Business Overview
2.3.2 Paclitaxel Injection Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Biological E.
2.4.1 Business Overview
2.4.2 Paclitaxel Injection Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Taj Accura
2.5.1 Business Overview
2.5.2 Paclitaxel Injection Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Khandelwal Laboratories
2.6.1 Business Overview
2.6.2 Paclitaxel Injection Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Luye Pharma
2.7.1 Business Overview
2.7.2 Paclitaxel Injection Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Beijing Youcare
2.8.1 Business Overview
2.8.2 Paclitaxel Injection Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Beijing Union
2.9.1 Business Overview
2.9.2 Paclitaxel Injection Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Haiyao
2.10.1 Business Overview
2.10.2 Paclitaxel Injection Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Chuntch
2.11.1 Business Overview
2.11.2 Paclitaxel Injection Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Chuntch Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Paclitaxel Injection Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Paclitaxel Injection Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Paclitaxel Injection Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Paclitaxel Injection Manufacturer Market Share in 2018
3.3.2 Top 6 Paclitaxel Injection Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Paclitaxel Injection Market Analysis by Regions
4.1 Global Paclitaxel Injection Sales, Revenue and Market Share by Regions
4.1.1 Global Paclitaxel Injection Sales and Market Share by Regions (2014-2019)
4.1.2 Global Paclitaxel Injection Revenue and Market Share by Regions (2014-2019)
4.2 North America Paclitaxel Injection Sales and Growth Rate (2014-2019)
4.3 Europe Paclitaxel Injection Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Paclitaxel Injection Sales and Growth Rate (2014-2019)
4.5 South America Paclitaxel Injection Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Paclitaxel Injection Sales and Growth Rate (2014-2019)
5 North America Paclitaxel Injection by Country
5.1 North America Paclitaxel Injection Sales, Revenue and Market Share by Country
5.1.1 North America Paclitaxel Injection Sales and Market Share by Country (2014-2019)
5.1.2 North America Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
5.2 United States Paclitaxel Injection Sales and Growth Rate (2014-2019)
5.3 Canada Paclitaxel Injection Sales and Growth Rate (2014-2019)
5.4 Mexico Paclitaxel Injection Sales and Growth Rate (2014-2019)
6 Europe Paclitaxel Injection by Country
6.1 Europe Paclitaxel Injection Sales, Revenue and Market Share by Country
6.1.1 Europe Paclitaxel Injection Sales and Market Share by Country (2014-2019)
6.1.2 Europe Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
6.2 Germany Paclitaxel Injection Sales and Growth Rate (2014-2019)
6.3 UK Paclitaxel Injection Sales and Growth Rate (2014-2019)
6.4 France Paclitaxel Injection Sales and Growth Rate (2014-2019)
6.5 Russia Paclitaxel Injection Sales and Growth Rate (2014-2019)
6.6 Italy Paclitaxel Injection Sales and Growth Rate (2014-2019)
7 Asia-Pacific Paclitaxel Injection by Country
7.1 Asia-Pacific Paclitaxel Injection Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Paclitaxel Injection Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
7.2 China Paclitaxel Injection Sales and Growth Rate (2014-2019)
7.3 Japan Paclitaxel Injection Sales and Growth Rate (2014-2019)
7.4 Korea Paclitaxel Injection Sales and Growth Rate (2014-2019)
7.5 India Paclitaxel Injection Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Paclitaxel Injection Sales and Growth Rate (2014-2019)
8 South America Paclitaxel Injection by Country
8.1 South America Paclitaxel Injection Sales, Revenue and Market Share by Country
8.1.1 South America Paclitaxel Injection Sales and Market Share by Country (2014-2019)
8.1.2 South America Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
8.2 Brazil Paclitaxel Injection Sales and Growth Rate (2014-2019)
8.3 Argentina Paclitaxel Injection Sales and Growth Rate (2014-2019)
8.4 Colombia Paclitaxel Injection Sales and Growth Rate (2014-2019)
9 Middle East and Africa Paclitaxel Injection by Countries
9.1 Middle East and Africa Paclitaxel Injection Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Paclitaxel Injection Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Paclitaxel Injection Sales and Growth Rate (2014-2019)
9.3 Turkey Paclitaxel Injection Sales and Growth Rate (2014-2019)
9.4 Egypt Paclitaxel Injection Sales and Growth Rate (2014-2019)
9.5 Nigeria Paclitaxel Injection Sales and Growth Rate (2014-2019)
9.6 South Africa Paclitaxel Injection Sales and Growth Rate (2014-2019)
10 Global Paclitaxel Injection Market Segment by Type
10.1 Global Paclitaxel Injection Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Paclitaxel Injection Sales and Market Share by Type (2014-2019)
10.1.2 Global Paclitaxel Injection Revenue and Market Share by Type (2014-2019)
10.2 Drug Strength Sales Growth and Price
10.2.1 Global Drug Strength Sales Growth (2014-2019)
10.2.2 Global Drug Strength Price (2014-2019)
10.3 Raw meterial Paclitaxel API source Sales Growth and Price
10.3.1 Global Raw meterial Paclitaxel API source Sales Growth (2014-2019)
10.3.2 Global Raw meterial Paclitaxel API source Price (2014-2019)
11 Global Paclitaxel Injection Market Segment by Application
11.1 Global Paclitaxel Injection Sales Market Share by Application (2014-2019)
11.2 Ovarian cancer Sales Growth (2014-2019)
11.3 Breast cancer Sales Growth (2014-2019)
11.4 Cervical cancer Sales Growth (2014-2019)
11.5 Pancreatic cancer Sales Growth (2014-2019)
11.6 Other Sales Growth (2014-2019)
12 Paclitaxel Injection Market Forecast (2019-2024)
12.1 Global Paclitaxel Injection Sales, Revenue and Growth Rate (2019-2024)
12.2 Paclitaxel Injection Market Forecast by Regions (2019-2024)
12.2.1 North America Paclitaxel Injection Market Forecast (2019-2024)
12.2.2 Europe Paclitaxel Injection Market Forecast (2019-2024)
12.2.3 Asia-Pacific Paclitaxel Injection Market Forecast (2019-2024)
12.2.4 South America Paclitaxel Injection Market Forecast (2019-2024)
12.2.5 Middle East and Africa Paclitaxel Injection Market Forecast (2019-2024)
12.3 Paclitaxel Injection Market Forecast by Type (2019-2024)
12.3.1 Global Paclitaxel Injection Sales Forecast by Type (2019-2024)
12.3.2 Global Paclitaxel Injection Market Share Forecast by Type (2019-2024)
12.4 Paclitaxel Injection Market Forecast by Application (2019-2024)
12.4.1 Global Paclitaxel Injection Sales Forecast by Application (2019-2024)
12.4.2 Global Paclitaxel Injection Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Paclitaxel Injection Picture
Table Product Specifications of Paclitaxel Injection
Figure Global Sales Market Share of Paclitaxel Injection by Types in 2018
Table Paclitaxel Injection Types for Major Manufacturers
Figure Drug Strength Picture
Figure Raw meterial Paclitaxel API source Picture
Figure Paclitaxel Injection Sales Market Share by Applications in 2018
Figure Ovarian cancer Picture
Figure Breast cancer Picture
Figure Cervical cancer Picture
Figure Pancreatic cancer Picture
Figure Other Picture
Figure United States Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure France Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure UK Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure China Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure India Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Paclitaxel Injection Revenue (Value) and Growth Rate (2014-2024)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Paclitaxel Injection Type and Applications
Table Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Paclitaxel Injection Type and Applications
Table Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hospira Basic Information, Manufacturing Base and Competitors
Table Hospira Paclitaxel Injection Type and Applications
Table Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biological E. Basic Information, Manufacturing Base and Competitors
Table Biological E. Paclitaxel Injection Type and Applications
Table Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Taj Accura Basic Information, Manufacturing Base and Competitors
Table Taj Accura Paclitaxel Injection Type and Applications
Table Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Khandelwal Laboratories Basic Information, Manufacturing Base and Competitors
Table Khandelwal Laboratories Paclitaxel Injection Type and Applications
Table Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Luye Pharma Basic Information, Manufacturing Base and Competitors
Table Luye Pharma Paclitaxel Injection Type and Applications
Table Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Beijing Youcare Basic Information, Manufacturing Base and Competitors
Table Beijing Youcare Paclitaxel Injection Type and Applications
Table Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Beijing Union Basic Information, Manufacturing Base and Competitors
Table Beijing Union Paclitaxel Injection Type and Applications
Table Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Haiyao Basic Information, Manufacturing Base and Competitors
Table Haiyao Paclitaxel Injection Type and Applications
Table Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Chuntch Basic Information, Manufacturing Base and Competitors
Table Chuntch Paclitaxel Injection Type and Applications
Table Chuntch Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Paclitaxel Injection Sales by Manufacturer (2017-2018)
Figure Global Paclitaxel Injection Sales Market Share by Manufacturer in 2017
Figure Global Paclitaxel Injection Sales Market Share by Manufacturer in 2018
Table Global Paclitaxel Injection Revenue by Manufacturer (2017-2018)
Figure Global Paclitaxel Injection Revenue Market Share by Manufacturer in 2017
Figure Global Paclitaxel Injection Revenue Market Share by Manufacturer in 2018
Figure Top 3 Paclitaxel Injection Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Paclitaxel Injection Manufacturer (Revenue) Market Share in 2018
Figure Global Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Global Paclitaxel Injection Revenue and Growth Rate (2014-2019)
Table Global Paclitaxel Injection Sales by Regions (2014-2019)
Table Global Paclitaxel Injection Sales Market Share by Regions (2014-2019)
Table Global Paclitaxel Injection Revenue by Regions (2014-2019)
Figure Global Paclitaxel Injection Revenue Market Share by Regions in 2014
Figure Global Paclitaxel Injection Revenue Market Share by Regions in 2018
Figure North America Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Europe Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure South America Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure North America Paclitaxel Injection Revenue and Growth Rate (2014-2019)
Table North America Paclitaxel Injection Sales by Countries (2014-2019)
Table North America Paclitaxel Injection Sales Market Share by Countries (2014-2019)
Figure North America Paclitaxel Injection Sales Market Share by Countries in 2014
Figure North America Paclitaxel Injection Sales Market Share by Countries in 2018
Table North America Paclitaxel Injection Revenue by Countries (2014-2019)
Table North America Paclitaxel Injection Revenue Market Share by Countries (2014-2019)
Figure North America Paclitaxel Injection Revenue Market Share by Countries in 2014
Figure North America Paclitaxel Injection Revenue Market Share by Countries in 2018
Figure United States Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Canada Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Mexico Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Europe Paclitaxel Injection Revenue and Growth Rate (2014-2019)
Table Europe Paclitaxel Injection Sales by Countries (2014-2019)
Table Europe Paclitaxel Injection Sales Market Share by Countries (2014-2019)
Table Europe Paclitaxel Injection Revenue by Countries (2014-2019)
Figure Europe Paclitaxel Injection Revenue Market Share by Countries in 2017
Figure Europe Paclitaxel Injection Revenue Market Share by Countries in 2018
Figure Germany Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure UK Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure France Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Russia Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Italy Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Paclitaxel Injection Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Paclitaxel Injection Sales by Countries (2014-2019)
Table Asia-Pacific Paclitaxel Injection Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Paclitaxel Injection Sales Market Share by Countries 2018
Table Asia-Pacific Paclitaxel Injection Revenue by Countries (2014-2019)
Figure Asia-Pacific Paclitaxel Injection Revenue Market Share by Countries 2018
Figure China Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Japan Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Korea Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure India Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Southeast Asia Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure South America Paclitaxel Injection Revenue and Growth Rate (2014-2019)
Table South America Paclitaxel Injection Sales by Countries (2014-2019)
Table South America Paclitaxel Injection Sales Market Share by Countries (2014-2019)
Figure South America Paclitaxel Injection Sales Market Share by Countries in 2018
Table South America Paclitaxel Injection Revenue by Countries (2014-2019)
Table South America Paclitaxel Injection Revenue Market Share by Countries (2014-2019)
Figure South America Paclitaxel Injection Revenue Market Share by Countries in 2018
Figure Brazil Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Argentina Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Colombia Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Paclitaxel Injection Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Paclitaxel Injection Sales by Countries (2014-2019)
Table Middle East and Africa Paclitaxel Injection Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Paclitaxel Injection Sales Market Share by Countries in 2018
Table Middle East and Africa Paclitaxel Injection Revenue by Countries (2014-2019)
Table Middle East and Africa Paclitaxel Injection Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Paclitaxel Injection Revenue Market Share by Countries in 2014
Figure Middle East and Africa Paclitaxel Injection Revenue Market Share by Countries in 2018
Figure Saudi Arabia Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure UAE Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Egypt Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure Nigeria Paclitaxel Injection Sales and Growth Rate (2014-2019)
Figure South Africa Paclitaxel Injection Sales and Growth Rate (2014-2019)
Table Global Paclitaxel Injection Sales by Type (2014-2019)
Table Global Paclitaxel Injection Sales Share by Type (2014-2019)
Table Global Paclitaxel Injection Revenue by Type (2014-2019)
Table Global Paclitaxel Injection Revenue Share by Type (2014-2019)
Figure Global Drug Strength Sales Growth (2014-2019)
Figure Global Drug Strength Price (2014-2019)
Figure Global Raw meterial Paclitaxel API source Sales Growth (2014-2019)
Figure Global Raw meterial Paclitaxel API source Price (2014-2019)
Table Global Paclitaxel Injection Sales by Application (2014-2019)
Table Global Paclitaxel Injection Sales Share by Application (2014-2019)
Figure Global Breast cancer Sales Growth (2014-2019)
Figure Global Cervical cancer Sales Growth (2014-2019)
Figure Global Pancreatic cancer Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Paclitaxel Injection Sales, Revenue and Growth Rate (2019-2024)
Table Global Paclitaxel Injection Sales Forecast by Regions (2019-2024)
Table Global Paclitaxel Injection Market Share Forecast by Regions (2019-2024)
Figure North America Sales Paclitaxel Injection Market Forecast (2019-2024)
Figure Europe Sales Paclitaxel Injection Market Forecast (2019-2024)
Figure Asia-Pacific Sales Paclitaxel Injection Market Forecast (2019-2024)
Figure South America Sales Paclitaxel Injection Market Forecast (2019-2024)
Figure Middle East and Africa Sales Paclitaxel Injection Market Forecast (2019-2024)
Table Global Paclitaxel Injection Sales Forecast by Type (2019-2024)
Table Global Paclitaxel Injection Market Share Forecast by Type (2019-2024)
Table Global Paclitaxel Injection Sales Forecast by Application (2019-2024)
Table Global Paclitaxel Injection Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs